<DOC>
	<DOCNO>NCT00303589</DOCNO>
	<brief_summary>This 3 arm study compare efficacy safety beta-lactam 'standard care ' patient complicate skin skin structure infection require hospitalization . Patients randomize receive 1 ) beta-lactam 750mg iv q8h 2 ) beta-lactam 1500mg iv q8h 3 ) 'standard care ' [ PRP ( nafcillin flucloxacillin ) vancomycin , plus aztreonam ciprofloxacin ] . The anticipated time study treatment &lt; 3 month target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Beta-Lactam Hospitalized Patients With Skin Skin Structure Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>adult patient , &gt; =18 year age ; skin skin structure infection require hospitalization ; clinical diagnosis skin skin structure infection cause bacteria know suspected susceptible randomize study treatment ; material site infection clinically purulent seropurulent . presenting sustain shock ( SBP &lt; 90mm Hg &gt; 2 hour , despite adequate fluid resuscitation ) ; know suspect concomitant bacterial infection require antibiotic treatment ; skin infection chronic nonhealing ulcer &gt; 2 week duration ; patient surgery primary treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>